Study guide

17.2 Screening Programs & Pharmacist Role

APC Intern Written Examination Exam

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 Current Exam Facts 1.2 Pathway to General Registration 1.3 Restricted Open-Book Strategy (AMH & APF) 1.4 Scoring, Results & Appeals

2 Legal Framework: PBS & Medicine Schedules

2.1 PBS, Authority Prescriptions & Special Access Scheme 2.2 Schedules 2 & 3 (Pharmacy & Pharmacist Only Medicines) 2.3 Schedules 4 & 8 (Prescription Only & Controlled Drugs)

3 Legal Framework: Privacy, National Law & Pharmacy Board

3.1 Privacy, Confidentiality & Patient Rights 3.2 Health Practitioner National Law & Registration 3.3 Pharmacy Board Codes, Guidelines & Standards

4 Patient-Centred Medication Management

4.1 Assessing Clinical Situations & Treatment Options 4.2 Patient Factors: Adherence, Efficacy & Safety 4.3 Drug & Dosage-Form Factors 4.4 Culturally Responsive Medication Management

5 Primary Care & Judicious Use of Medicines

5.1 Primary Care & OTC Assessment 5.2 Judicious Use of Antimicrobials & High-Risk Agents 5.3 Non-Pharmacological Options & Evidence-Based OTC Choices

6 Dispensing & Clinical Appropriateness

6.1 Prescription Evaluation 6.2 Clinical Appropriateness Checks 6.3 Labelling, Packaging & Dispensing Standards 6.4 Communicating with Prescribers & Documenting Changes

7 Counselling & Acute Care

7.1 Patient-Centred Counselling 7.2 Confirming Understanding & Lifestyle Counselling 7.3 Acute Illness, Injury & Emergency Response

8 Therapeutics: Cardiovascular & Endocrine

8.1 Hypertension & Heart Failure 8.2 Ischaemic Heart Disease & Anticoagulation 8.3 Diabetes Medicines 8.4 Thyroid & Lipid Disorders

9 Therapeutics: Infection, Respiratory & Gastrointestinal

9.1 Anti-Infectives & Infection Management 9.2 Asthma & COPD 9.3 Gastrointestinal & Hepatic Conditions 9.4 Vaccination & Travel Health

10 Therapeutics: Neurology, Psychiatry & Pain

10.1 Epilepsy & Movement Disorders 10.2 Depression, Anxiety & Psychosis 10.3 Pain Management & Opioids 10.4 Migraine & Common Analgesics

11 Therapeutics: Special Populations & Systems

11.1 Women's Health, Contraception & Pregnancy 11.2 Dermatology, Ophthalmology & ENT 11.3 Renal/Hepatic Impairment & Dose Adjustment

12 Therapeutics: Rheumatology, Haematology, Urology, Oncology & Toxicology

12.1 Rheumatology: Gout, Osteoarthritis & Inflammatory Arthritis 12.2 Haematology: Anaemias & Blood Safety Monitoring 12.3 Urology & Men's Health 12.4 Oncology Support & Oral Anticancer Medicines 12.5 Toxicology & Poisoning Management

13 Monitoring: Clinical Review

13.1 Clinical Review Process 13.2 Interpreting Laboratory & Clinical Monitoring 13.3 Recommending Treatment Modifications

14 Monitoring: Safety & Adverse Drug Reactions

14.1 Adverse Drug Reactions & Reporting 14.2 Allergies, Sensitivities & Cross-Reactivity 14.3 High-Risk Medicines Monitoring

15 Compounding Medicines

15.1 Determining Required Formulations 15.2 Compounding Standards & Quality 15.3 Patient-Specific Preparations

16 Pharmaceutical Calculations

16.1 Dosage Calculations 16.2 Concentrations, Dilutions & Alligation 16.3 Half-Life & Basic Kinetic Calculations

17 Promote Health & Well-Being

17.1 National & Local Health Priorities 17.2 Screening Programs & Pharmacist Role 17.3 Culturally Responsive Promotion & Self-Sufficiency

17.2 Screening Programs & Pharmacist Role

Key Takeaways Explain This Topic AI

Opportunistic pharmacy screening (blood pressure, diabetes risk conversation, bowel screening kit awareness, skin cancer and mental health signposting) supports early detection when consented, private, and linked to referral.

Screening is not diagnosis: do not overclaim what a single test or checklist can prove, and explain limits in plain language.

Consent, privacy, and quality use of tests (validated tools, correct technique, documentation) are non-negotiable.

Know local referral pathways and when abnormal or high-risk findings need urgent medical or emergency review.

National programs (for example bowel screening) have defined target groups and pathways—promote awareness and access rather than inventing parallel diagnostic services.

Last updated: August 2026

16.2 Screening Programs & Pharmacist Role

Quick Answer: Screening finds possible risk or early disease in people who may feel well. In pharmacy, the intern-level role is opportunistic, consented, and referral-linked support—blood pressure checks, diabetes risk assessment conversations, awareness of national bowel screening kits, skin cancer awareness with medical referral, and mental health signposting—not running an unregulated diagnostic clinic. Always respect limits of screening , privacy , quality use of tests , and urgent review rules when results or symptoms are high risk.

Standard 3.6 pairs health priorities with practical early-detection behaviours. Exam stems punish both extremes: ignoring an obvious screening opportunity, and overcalling a diagnosis from one pharmacy measurement.

Screening versus diagnosis versus case-finding

Use precise language with patients and in exam answers:

Concept Meaning in pharmacy

Screening Applying a test or structured check to detect risk or possible disease early, often before symptoms. Results usually need confirmation.

Diagnosis Clinically establishing a disease—generally a medical process using history, examination, and confirmatory tests.

Case-finding Looking more carefully in people already known to be at higher risk (for example BP checks in someone on antihypertensives).

Monitoring Tracking known disease or therapy (for example home BP log for treated hypertension)—related but not the same as population screening.

A pharmacy BP of 168/98 mmHg is a finding that needs medical follow-up, not a spoken diagnosis of “you have hypertension, stage …”. A positive bowel screening kit is a signal for colonoscopy pathways , not a cancer diagnosis. This distinction is a frequent APC-style trap.

  • Opportunistic screening appropriate to pharmacy
  • Blood pressure

BP measurement is among the most useful pharmacy screening-support activities for cardiovascular priority work. Competence concepts include:

Offering the check in a way that allows refusal without embarrassment.

Using a validated device and appropriate cuff size.

Positioning (seated, back supported, feet on floor, arm supported at heart level) and a brief rest when practical.

Avoiding measurement over clothing that interferes with the cuff, and noting recent caffeine, smoking, or exercise if the patient reports them.

Recording systolic/diastolic values, pulse if taken, date/time, and which arm if relevant.

Explaining results in plain language: what was measured, that one reading is a snapshot, and what happens next.

Red-flag patterns (severe elevation, chest pain, dyspnoea, neurological symptoms, confusion, severe headache) shift the encounter from “routine screen” to urgent medical or emergency care . Do not send someone home with “come back next week” messaging when red flags are present.

Blood glucose and diabetes risk assessment (concepts)

Pharmacy may support risk conversation and, in some services, point-of-care glucose checks under local protocols. Critical points for the exam:

Capillary glucose is not a full diagnostic work-up for diabetes; diagnosis uses medical assessment and appropriate laboratory criteria.

Risk tools and questions (for example age, family history, ethnicity, gestational diabetes history, physical activity, weight) help triage who needs GP review—not to label someone “diabetic” at the counter.

Hypoglycaemia symptoms in a person on insulin or sulfonylureas are an acute clinical issue, not a screening discussion.

Very high glucose with symptoms (polyuria, polydipsia, weight loss, vomiting, drowsiness) needs prompt medical care; consider emergency pathways if the person is acutely unwell.

Quality use of any glucose meter includes training, quality control where required by the service model, infection control for lancets, and safe sharps disposal.

National bowel screening kit awareness

Australia’s National Bowel Cancer Screening Program invites eligible people in defined age bands to complete an immunochemical faecal occult blood test (iFOCT/FIT-style kit) at home. Pharmacists contribute by:

Explaining why screening matters (early detection of bowel cancer and pre-cancerous change).

Helping people understand invitation letters and kits when they ask, without replacing program instructions.

Encouraging completion and return of kits rather than dismissing “I feel fine.”

Stressing that a positive kit result requires follow-up investigation via the medical pathway, and a negative result is not a lifetime guarantee—symptoms such as rectal bleeding, iron-deficiency anaemia, persistent change in bowel habit, or unexplained weight loss still need medical review even after a negative screen.

Do not invent alternative “pharmacy cancer tests” as substitutes for the national program. Do not interpret a kit result as a definitive cancer diagnosis.

Skin cancer awareness — refer, do not diagnose from the counter

Australia has high skin cancer incidence. Pharmacy roles that are defensible include sun-protection advice (shade, clothing, broad-spectrum sunscreen use concepts), encouraging regular skin checks with GPs or skin clinics as appropriate, and urging medical review of changing moles, non-healing sores, or lesions that bleed or itch. What is not appropriate is confidently diagnosing melanoma or “it’s nothing” from a brief look over the counter under poor light. When in doubt, refer .

Mental health signposting

Mental health screening in pharmacy is usually conversational and risk-aware , not formal psychiatric diagnosis. Useful actions:

Private space when possible; open, non-judgemental questions.

Listening for functional decline, hopelessness, substance escalation, or carer distress.

Signposting to GP , mental health services, and crisis supports (for example Lifeline, Beyond Blue—use current local numbers/resources in practice).

Recognising suicidal ideation, plans, or severe agitation as urgent situations requiring immediate appropriate help, not a “come back if it gets worse” leaflet alone.

Pharmacy staff should know workplace protocols for distressed persons and when to involve emergency services.

Limits of screening — avoid diagnostic overclaim

Every screening modality has false positives and false negatives . Communicate this honestly:

  • “This reading is higher than usual targets—your doctor needs to confirm and decide next steps.”
  • “A positive bowel kit does not mean you definitely have cancer; it means further tests are needed.”
  • “A normal check today does not mean you will never develop the condition.”

Overclaim harms patients (unnecessary panic or false reassurance) and is professionally unsafe. Exam correct options usually include limitation language plus a clear next step .

Consent and privacy

Screening is a health intervention. Apply Australian privacy and professional confidentiality concepts:

Explain what you propose, why, and what you will do with the result.

Obtain agreement —implied consent may cover a simple BP offer the patient accepts, but sensitive mental health or body-related discussions need careful, private consent.

Protect visibility and audibility —move away from the open queue when results or history are sensitive.

Share results only with the patient (and others with appropriate authority/consent), and with clinicians via agreed referral pathways.

Record according to workplace clinical governance if the service is part of a formal program.

Forcing a “free health check” that a person does not want is neither ethical nor effective. Coercing partners or family members to receive results breaches confidentiality unless lawful exceptions apply (for example serious and imminent threat pathways—handle via senior protocols, not casual disclosure).

Referral pathways and urgent medical review

Build a mental map of who and how fast :

  • Finding / situation Typical pathway concept
  • Mild–moderate asymptomatic BP elevation GP review; lifestyle advice; recheck plan
  • Severely elevated BP with acute symptoms Urgent medical / emergency assessment
  • Diabetes risk factors or abnormal glucose without acute illness GP for confirmatory testing and management
  • Symptomatic hyperglycaemia / unwell person Urgent medical care; emergency if severe
  • Positive bowel screening kit Program/GP pathway to investigation
  • Bowel symptoms regardless of kit GP review (do not wait for the next kit cycle alone)
  • Suspicious skin lesion GP / skin clinic
  • Mental health distress without immediate danger GP and community mental health supports
  • Suicidal plan, acute psychosis, severe risk Emergency / crisis response per protocol

Write referrals that are factual : measurement, symptoms, medicines, and what you advised. Avoid speculative diagnostic labels.

Quality use of tests and devices

“Quality use” for screening tools mirrors quality use of medicines principles:

Right test for the question (do not use random tools that confuse patients).

Right technique and device maintenance.

Right person (eligibility, age group for national programs, clinical appropriateness).

Right interpretation within competence.

Right follow-up —a test without a pathway wastes resources and can harm.

Infection control and calibration where relevant.

If your pharmacy offers a structured screening service, follow the protocol , training, and documentation required for that service. If you lack training for a particular test, do not improvise—promote the appropriate external pathway instead.

Putting it together at the counter

A practical script pattern for exam reasoning:

Spot opportunity (priority condition, age group, medicines, conversation cue).

Offer screening or program awareness with plain purpose statement.

Gain consent; ensure privacy.

Perform or explain within competence and quality standards.

Interpret with humility (limits).

Act: lifestyle advice if appropriate, document, refer at the correct urgency .

Invite return questions; avoid abandoning the person after a worrying result.

Screening programs and opportunistic checks make Standard 3.6 concrete: early signals, safe language, and a door that opens toward medical care—not a closed diagnostic shopfront.